Merck (MRK) FCF Payout Ratio (2009 - 2026)

Merck (MRK) reported FCF Payout Ratio of 0.72 for Q1 2026, down 58.88% year-over-year from 1.75 in Q1 2025, and down 35.0% quarter-over-quarter from 1.11 in Q4 2025.

Merck (MRK) FCF Payout Ratio (2009 - 2026) Analysis & Trends

Merck (MRK) has 18 years of FCF Payout Ratio data on file, last reported at 0.72 in Q1 2026.

  • FCF Payout Ratio for Q1 2026 came in at 0.72, down 58.88% year-over-year; the trailing twelve-month figure through Mar 2026 was 0.58 (up 25.14% YoY), and the FY2025 annual result was 0.66, up 52.68% from the prior year.
  • FCF Payout Ratio eased to 0.72 in Q1 2026 per MRK's latest filing, from 1.11 in the prior quarter.
  • Over five years, FCF Payout Ratio peaked at 5.58 in Q1 2023 and troughed at 2.49 in Q4 2023.
  • A 5-year average of 0.76 and a median of 0.56 in 2022 frame the typical range for FCF Payout Ratio.
  • On a YoY basis, FCF Payout Ratio climbed as much as 1108.06% in 2023 and fell as far as 567.33% in 2023.
  • A 5-year view of FCF Payout Ratio shows it stood at 0.53 in 2022, then slumped by 567.33% to 2.49 in 2023, then soared by 131.15% to 0.78 in 2024, then soared by 42.51% to 1.11 in 2025, then plunged by 35.0% to 0.72 in 2026.
  • Business Quant data shows MRK's FCF Payout Ratio at 0.72 in Q1 2026, 1.11 in Q4 2025, and 0.3 in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) FCF Cover (Qtr)
1 Gsk 92,316,836.42 Bn 92,316,831.46 Bn 7.76 Bn -0.41
2 Eli Lilly 983.57 Bn 978.29 Bn 16.22 Bn 0.51
3 Johnson & Johnson 553.56 Bn 531.50 Bn 15.96 Bn 2.14
4 AbbVie 383.35 Bn 374.00 Bn 10.78 Bn 0.87
5 Merck 281.71 Bn 276.06 Bn 12.09 Bn 0.72
6 Amgen 182.20 Bn 170.16 Bn 5.87 Bn 0.92
7 Gilead Sciences 153.71 Bn 145.98 Bn 5.52 Bn 0.43
8 Pfizer 143.75 Bn 130.98 Bn -1.21 Bn 1.12
9 Bristol Myers Squibb 109.71 Bn 99.25 Bn 8.07 Bn 1.69
10 Novartis Ag 108.28 Bn 107.60 Bn - -

Historic Data

Download Data
DateValue
Mar 31, 2026 0.72
Dec 31, 2025 1.11
Sep 30, 2025 0.30
Jun 30, 2025 0.82
Mar 31, 2025 1.75
Dec 31, 2024 0.78
Sep 30, 2024 0.23
Jun 30, 2024 0.41
Mar 31, 2024 0.87
Dec 31, 2023 -2.49
Sep 30, 2023 0.27
Jun 30, 2023 0.69
Mar 31, 2023 5.58
Dec 31, 2022 0.53
Sep 30, 2022 0.39
Jun 30, 2022 0.56
Mar 31, 2022 0.46
Dec 31, 2021 0.42
Sep 30, 2021 0.45
Jun 30, 2021 1.67